CRP and stroke disorder: Furthermore, biomarkers like high-sensitivity C-reactive protein (hs-CRP), plasminogen activator inhibitor-1, and lipoprotein-associated phospholipase A2 (Lp-PLA2) have also been studied for their role in the prediction of disease progression and recurrent stroke occurrence [17,18].